SCHEMBL5202843

SCHEMBL5202843

N#CCOc1ccc(O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 4/20 0.47
▸ LMNA P02545 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ CA12 O43570 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA3 P07451 1/20 0.46
▸ CA6 P23280 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ CA14 Q9ULX7 1/20 0.46
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ ESR2 Q92731 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3468860 0.79 ESR1 (0.56) SLC6A2SLC6A3ESR1ESR2APP
SCHEMBL6574222 0.79 MAOB (0.53) CA12CA2CA3CA6CA9
SCHEMBL634910 0.78 LTA4H (0.45) LTA4HMEN1KMT2ASYK
SCHEMBL10610940 0.78 GAA (0.58) LTA4HLMNACYP1A2PTGS1SLC6A2
SCHEMBL27895120 0.78 LMNA (0.41) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL27925496 0.77 EGFR (0.39) SYK
SCHEMBL4652388 0.77 APP (0.50) APPSYK
SCHEMBL3472112 0.77 SYK (0.43) CA12CA2CA9SYK
SCHEMBL975819 0.77 CA12 (0.53) LTA4HLMNACYP1A2PTGS1SLC6A2
SCHEMBL2641227 0.77 LTA4H (0.47) LTA4HLMNACYP1A2PTGS1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 — — EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 — — US disclosed
US-5952362-A INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY SYNTEX (U.S.A) INC. (US) 1999-09-14 — — US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 — — EP disclosed
EP-0129851-B1 PREPARATION OF MONOALKYLATED DIHYDROXYBENZENES AND NOVEL COMPOUNDS PREPARED THEREBY THE DOW CHEMICAL COMPANY (US) 1988-07-13 — — EP disclosed
US-4691042-A Preparation of monaoalkylated dihydroxybenzenes and novel compounds prepared thereby THE DOW CHEMICAL COMPANY (US) 1987-09-01 — — US disclosed
US-4568497-A Preparation of monoalkylated dihydroxybenzenes THE DOW CHEMICAL COMPANY (US) 1986-02-04 — — US disclosed
US-4511731-A 2-Ethoxyethyl 2-(4-hydroxyphenoxy)-propanoate THE DOW CHEMICAL COMPANY (US) 1985-04-16 — — US disclosed
EP-0129851-A2 Preparation of monoalkylated dihydroxybenzenes and novel compounds prepared thereby THE DOW CHEMICAL COMPANY (US) 1985-01-02 — — EP disclosed
Send feedback